Part BOutcome & teaching note

Serial Acquirer Economics And Governance · 2014–2025

TransDigm proprietary-aftermarket acquisition compounding

The Part A exercise authorized no simulated capital or external trade; this outcome reveal therefore evaluates TransDigm's realized business trajectory and the quality of the frozen defer-and-re-underwrite process, not an undocumented learner portfolio return.

Outcome-reveal packet. Read only after freezing Part A. The canonical Part A bundle was frozen at 2026-08-16T18:19:36Z with SHA-256 2f35f9555b591514ca000c5fd3cafa7956116bcd166fc7574dd2f574e73e129c; its rendered report SHA-256 is c4f7d3b17ec9099af426f0d0542466e053bec9aeef532293a6477fb45b69ff71. This report's evidence and knowledge cutoff is August 16, 2026 at 20:17:30 UTC. Its economic endpoint remains September 30, 2025. Separately, it evaluates the FY2025 filing-date count stated on November 12, 2025: that count includes Simmonds, which closed October 6, 2025, and is not the September 30 operating perimeter. The later knowledge cutoff is required because the exact issuer-hosted PDF carriers used for citation were not verified as publicly available until the August 2026 browser observations.

Executive summary

Outcome: bounded operating success; broader underwriting unresolved. TransDigm materially expanded reported revenue, GAAP profit and operating cash flow through September 30, 2025. FY2014-to-FY2025 revenue increased by USD 6,458.094 million, a deterministic 12.689768% CAGR, and operating margin increased by 8.062822 percentage points. Separately, the issuer-stated cumulative count rose from 55 at the FY2015 filing date to 95 in the FY2025 filing; the 95 includes Simmonds, acquired after fiscal year-end, and is not the FY2025 operating perimeter. These measures support operating capacity through September 30 and transaction capacity through the later filing—not valuation, total shareholder return, acquisition-cohort IRR, customer surplus, covenant resilience, solvency or ethical innocence. [judgment.transdigm.outcome.bounded-business-success; table.transdigm.outcome.long-horizon; table.transdigm.outcome.acquisition-count]

The frozen decision process remains sound. Part A authorized no simulated capital or trade and recommended deferral until six non-substitutable gates were re-underwritten. Strong hindsight does not retroactively provide the cutoff security price, diluted capitalization, cohort cash returns, stressed funding schedule or customer-harm controls that were missing. No actual learner portfolio return is documented. [judgment.transdigm.cutoff.defer-reunderwrite; judgment.transdigm.outcome.process-remains-sound; claim.transdigm.outcome.valuation-and-return-gap]

Government-pricing evidence is critical opposition, with precise limits. DoD OIG reports found benchmark-defined excess profit and restricted procurement-stage access to uncertified cost data in sampled sole-source spare-parts contracts. They also said contracting officers followed allowed procedures, the 15% figure was an audit benchmark rather than a fixed-price profit ceiling, and TransDigm complied with the certified-data requirement for the sampled above-threshold contract. The evidence does not establish illegality or portfolio-wide customer harm; the selected record also does not establish completed remediation or payment of a voluntary refund. [claim.dodig.outcome.transdigm-2019-findings; claim.dodig.outcome.transdigm-2022-findings; claim.dodig.outcome.transdigm-method-boundary; claim.dodig.outcome.transdigm-remediation-status]

Capital-market abstention remains mandatory. This packet does not calculate a target price, historical trade verdict, total shareholder return or position size. It contains no governed market-price series, complete capitalization bridge, acquisition-cohort returns, stressed covenant model or approved customer-outcome conclusion. [claim.transdigm.outcome.valuation-and-return-gap]

What happened

The FY2015 filing disclosed that Telair Cargo Group closed on March 26, 2015 and was one of four acquisitions contributing to acquisition sales that year. TransDigm remained profitable and operating-cash-flow positive while reporting USD 1,624.278 million of acquisition cash use. As of the FY2015 filing date, the company said it had acquired 55 businesses and product lines since 1993. [claim.transdigm.outcome.acquisition-perimeter; evidence.transdigm.outcome.fy2015-cash-flow; evidence.transdigm.outcome.fy2015-acquisition-system]

The 2019 and 2022 DoD OIG reports then supplied material contrary evidence about sampled government spare-parts pricing, cost-data access and procurement policy. At the September 30, 2025 operating endpoint, TransDigm reported substantially greater consolidated scale, large special distributions and new debt. Separately, the filing accepted November 12, 2025 stated a cumulative count of 95 businesses and product lines. [claim.dodig.outcome.transdigm-2019-findings; claim.dodig.outcome.transdigm-2022-findings; claim.transdigm.outcome.gaap-scale; claim.transdigm.outcome.funding-and-distributions; claim.transdigm.outcome.acquisition-perimeter; evidence.transdigm.outcome.fy2025-business-model; evidence.transdigm.outcome.fy2025-acquisitions]

Simmonds is included in the filing-date count of 95 but excluded from FY2025 operating results and the September 30 operating perimeter because it closed on October 6, 2025. The FY2025 acquisition cash-flow line was USD 419 million; management separately described approximately USD 413 million of FY2025 acquisitions net of cash acquired, including Servotronics at approximately USD 133 million. Those related disclosures are kept distinct. [claim.transdigm.outcome.acquisition-perimeter; evidence.transdigm.outcome.fy2025-acquisitions; evidence.transdigm.outcome.fy2025-cash-flow]

Financial outcome

GAAP and cash-flow endpoints

USD millions except where noted:

MetricFY2014FY2015FY2025
Net sales2,372.9062,707.1158,831
Gross profit1,267.8741,449.8455,311
Income from operations927.8201,074.0024,165
Net income306.910447.2122,074
Interest expense-net347.688418.7851,572
Net cash provided by operating activities541.222520.9382,038
Capital expenditures (FY2015 net of disposals; positive cash-use magnitude)34.14654.871222
Cash and cash equivalents at year-end819.548714.0332,808

These are filed GAAP or cash-flow coordinates, not adjusted EBITDA. The FY2015 USD 54.871 million source label is “Capital expenditures, net of disposals”; the FY2014 and FY2025 selected labels are “Capital expenditures.” [claim.transdigm.outcome.gaap-scale; table.transdigm.outcome.gaap-endpoints; evidence.transdigm.outcome.fy2015-income; evidence.transdigm.outcome.fy2015-cash-flow; evidence.transdigm.outcome.fy2025-income]

Deterministic profitability and interest checks

MetricFY2014FY2015FY2025
Gross margin53.431278%53.556831%60.140414%
Operating margin39.100580%39.673305%47.163402%
Net margin12.933930%16.519874%23.485449%
Interest expense-net / net sales14.652414%15.469790%17.800929%
Operating income / interest expense-net2.668542x2.564567x2.649491x

The last row is a descriptive ratio, not covenant interest coverage. The deterministic run is complete and replayed locally but deliberately non-authoritative because it lacks a governed registry, signed execution receipt and frozen evaluation-suite approval. [table.transdigm.outcome.margins-and-interest; table.transdigm.outcome.funding-scale; model-run.transdigm.outcome.matched-horizon]

Its exact provenance is:

  • Code SHA-256: 3cde9d78f192109a4bb16e2f8ca8828f7501dc1c4dc5508345a9e67a4ae9caa2
  • Canonical invocation SHA-256: aa81c28c07c73d0236477009ad1766edebb3f8f15c94fbbdbe9788f9348e7278
  • Canonical result SHA-256: ab215feb59202367ac602aa3fb8311955a999ee1719142e28e8f2bdf9e996aee

The replay asserted every expected output under an isolated decimal context and repeated the calculation under hostile ambient precision, rounding, exponent, clamp and trap settings, then verified context restoration.

Organic and acquisition bridge

BridgeFY2015 vs FY2014FY2025 vs FY2024
Organic sales change, USDm78.0615
Acquisition sales change, USDm256.2276
Total reported net-sales change, USDm334.209891
Reported net-sales growth14.084376%11.221662%
Organic share of precise total change23.338689%69.023569%
Acquisition share of precise total change76.658618%30.976431%

The classifications are issuer-defined: acquisition sales cover acquired businesses for up to one year after acquisition. FY2015's disclosed bridge components were rounded to USD 334.2 million while the precise GAAP endpoint difference is USD 334.209 million, so the two derived shares do not sum to exactly 100%. FY2025 management attributed the organic increase primarily to defense and commercial aftermarket. Neither bridge isolates price, volume, mix, customer value, reinvestment or cohort return. [claim.transdigm.outcome.sales-bridges; claim.transdigm.outcome.end-market-rival; table.transdigm.outcome.sales-bridge; table.transdigm.outcome.sales-change-composition]

Cash, debt and distributions

MetricFY2014FY2015FY2025
Analyst-selected reported debt scale, USDm7,473.1318,427.34230,015
Reported debt scale less cash, USDm6,653.5837,713.30927,207
OCF less selected capital-expenditure residual, USDm (FY2015 net of disposals)507.076466.0671,816
Reported debt scale / OCF13.807885x16.177246x14.727674x

Debt boundary: FY2015 is the analyst sum of USD 43.840 million current debt, USD 8,183.502 million long-term debt and USD 200.000 million receivables-securitization borrowing. FY2025 is the analyst sum of the filing's USD 29,291 million net long-term-debt schedule aggregate—including refundable advances and finance leases—and the separately reported USD 724 million securitization borrowing. The FY2014 frozen fact is likewise a reconstructed carrying-value scale. These are non-comparable endpoint perimeters, not issuer-defined covenant debt, a solvency conclusion or a restated series. The USD 22,541.869 million endpoint change is therefore descriptive only. [claim.transdigm.outcome.debt-perimeter-boundary; table.transdigm.outcome.funding-scale; table.transdigm.outcome.long-horizon]

Cash boundary: operating cash flow less the selected capital-expenditure cash-use magnitude is only an arithmetic residual; the FY2015 input is specifically net of disposals. It is never free cash flow and omits acquisitions, financing, distributions and other cash claims.

FY2025 acquisition cash use was USD 419 million, or 23.072687% of the OCF-less-capex residual. Dividends and dividend-equivalent payments were USD 9,629 million, or 472.473013% of operating cash flow. The September 2025 special dividend and equivalents totaled USD 5,232 million; USD 5,000 million of new debt equaled 95.565749% of that payment, with existing cash funding the balance. None of these ratios is a return or covenant test. [claim.transdigm.outcome.funding-and-distributions; table.transdigm.outcome.fy2025-capital-allocation]

Government-pricing opposition

DODIG-2019-060 reported:

  • benchmark-defined excess profit on 46 of 47 sampled parts and 112 of 113 sampled contracts;
  • sampled profit percentages of 17% to 4,451%, using 15% or less as the audit's reasonable-profit benchmark;
  • USD 16.1 million of benchmark-defined excess profit on USD 26.2 million of sampled sales from January 2015 through January 2017;
  • 15 denied requests for uncertified cost data out of 16 cost-data requests, with the one certified-data request fulfilled; and
  • 39 of 47 sampled parts manufactured only by TransDigm.

The report simultaneously said contracting officers followed allowed FAR and DFARS procedures. [claim.dodig.outcome.transdigm-2019-findings; evidence.dodig.outcome.transdigm-2019-findings; evidence.dodig.outcome.transdigm-2019-cost-data]

DODIG-2022-043 reported:

  • more than 95% of the TransDigm contracts in its January 2017-to-June 2019 review period, valued at USD 268.2 million, were below the TINA threshold;
  • requested uncertified cost data for 26 of 107 parts on 27 of 153 contracts, with operating units supplying it for 2 parts on 2 contracts during procurement and not for 24 parts on 25 contracts;
  • audit-stage cost data ultimately obtained for 152 of 153 sampled contracts; and
  • at least USD 20.8 million of benchmark-defined excess profit on 105 parts and 150 contracts.

The OIG expressly rejected interpreting its 15% audit benchmark as a fixed-price profit ceiling. It recorded TransDigm's market-pricing position, stated that the above-threshold certified-data requirement had been met in the earlier sample and did not characterize the sampled prices as illegal. [claim.dodig.outcome.transdigm-2022-findings; claim.dodig.outcome.transdigm-method-boundary; evidence.dodig.outcome.transdigm-2022-findings; evidence.dodig.outcome.transdigm-2022-cost-data-requests; evidence.dodig.outcome.transdigm-2022-method-boundary; evidence.dodig.outcome.transdigm-2022-certified-data-boundary]

The 2022 report described a DPC-DLA-TransDigm working group and recommendations that were resolved but open until agreed actions were verified. Accordingly, completed closure, voluntary-refund payment and aggregate customer harm remain unknown in this packet. The FY2025 filing itself continued to disclose pricing-review, cost-based-pricing and alternate-source risk; that is issuer risk disclosure, not proof of remediation. [claim.dodig.outcome.transdigm-remediation-status; evidence.dodig.outcome.transdigm-2022-remediation; evidence.dodig.outcome.transdigm-2022-recommendation-status; evidence.transdigm.outcome.fy2025-government-risk]

Six-gate outcome assessment

Frozen gateOutcome assessmentWhy
Product necessity, switching and lifecyclePartialThe proprietary and aftermarket mix remained high by issuer estimate, but no independent product-level necessity, switching, remaining-life or customer-value ledger was supplied.
Organic commercial enginePartialThe FY2025 issuer bridge showed USD 615 million of organic-sales growth versus USD 276 million of acquisition-sales growth, but price, volume, mix and external demand remain unseparated.
Acquisition diligence, integration and reinvestmentNot clearedThe filing-date transaction count reached 95 and includes post-year-end Simmonds; it is not the FY2025 operating perimeter, and stable purchase-price-to-realized-cash-return cohorts and IRRs are absent.
GAAP, adjusted measures and earnings-to-cashStrong reconstruction; no FCF conclusionGAAP statements and cash flow reconcile, margins are deterministic, and OCF less the selected capital-expenditure cash-use magnitude is explicitly only a residual; the FY2015 input is net of disposals.
Debt, interest, liquidity, covenants and refinancingNot clearedCash generation expanded, but selected debt scale, interest and distributions were also large; there is no complete stressed maturity and covenant model.
Governance, customer harm and valuationNot clearedOIG findings are material opposition; legal and method limits matter; remediation, portfolio-wide customer outcomes, price attractiveness and returns remain unknown.

No favorable gate offsets a failed or incomplete one. [judgment.transdigm.outcome.process-remains-sound; conflict.transdigm.outcome.operating-advantage-versus-customer-harm; conflict.transdigm.outcome.scale-versus-cohort-return; conflict.transdigm.outcome.cash-capacity-versus-funding-resilience]

Causal analysis

The primary hypothesis is multifactor compounding: proprietary installed-base exposure and aftermarket recurrence supplied demand; acquisitions present in operations by September 30 broadened the operating perimeter; operating execution converted scale into GAAP profit and cash; and financing access enabled continued acquisition and distributions. Simmonds is excluded from that FY2025 operating mechanism. This hypothesis has moderate confidence because the aggregate record cannot assign causal weights. [hypothesis.transdigm.outcome.multifactor-compounding]

Two rivals remain live:

  1. Perimeter and demand. The filing-date count rose by 40, but the later count includes Simmonds after FY2025 and is not an operating-perimeter bridge. Acquisitions actually present by September 30 plus commercial-aftermarket and defense demand could still explain much of the endpoint without a uniquely superior operating system. [hypothesis.transdigm.outcome.perimeter-and-demand]
  2. Pricing capture. Proprietary and sole-source positions, including sampled government-spares pricing, could explain part of margin expansion. The OIG samples and method do not support extrapolating this as the dominant portfolio-wide cause. [hypothesis.transdigm.outcome.pricing-capture]

The missing experiment is a matched product-and-acquisition cohort bridge controlling for acquisition dates, price, volume, mix, end-market demand, necessary reinvestment and financing. [assumption.transdigm.outcome.aggregate-attribution-limit]

Decision process versus outcome

The outcome does not invalidate the frozen defer-and-re-underwrite recommendation. A favorable realized business trajectory can follow a disciplined abstention when the proposed security action lacks a governed price, capitalization, downside funding model or authority. Conversely, strong business performance does not prove that every acquisition or distribution created value. Process quality and outcome quality remain separate. [judgment.transdigm.outcome.process-remains-sound]

The nearest feasible counterfactual was to retain the no-add posture and condition later acquisition or distribution funding on predeclared cohort-return, customer-outcome and stressed-liquidity gates. It is not possible to quantify the counterfactual's lost scale, lower debt or security return from this record. [counterfactual.transdigm.outcome.stage-capital; assumption.transdigm.outcome.staged-capital-counterfactual]

What was genuinely observable at the cutoff

  • Proprietary, sole-source and aftermarket claims were visible alongside explicit government fair-and-reasonable-pricing review risk. This duality was not hindsight. [evidence.transdigm.cutoff.business-model; evidence.transdigm.cutoff.government-pricing-risk]
  • Filed bridges already showed acquisition-versus-organic composition, while acquisition-cohort returns were absent. [evidence.transdigm.cutoff.fy2014-sales-bridge; evidence.transdigm.cutoff.q1-sales-bridge; evidence.transdigm.cutoff.q1-acquisition-gross-profit]
  • Operating cash flow coexisted with debt growth, interest, a special dividend and the signed Telair commitment. Scale did not establish funding resilience. [evidence.transdigm.cutoff.fy2014-balance-cashflow; evidence.transdigm.cutoff.q1-cash-flow; evidence.transdigm.cutoff.dividend-financing; evidence.transdigm.cutoff.telair-agreement]
  • The issuer explicitly kept adjusted EBITDA measures separate from GAAP income and operating cash flow. [evidence.transdigm.cutoff.non-gaap-boundary]

Each signal had false-positive risk: proprietary products can create genuine value, acquisition-led growth can earn high returns, debt can be resilient, and non-GAAP measures can be useful when fully reconciled. None alone predicted the later outcome.

Transferable candidate rules

Separate moat from customer outcomes. When proprietary or sole-source economics serve governments or safety-critical customers, separately test product necessity, price-cost-value, qualified alternatives, quality, legal compliance, audit findings and remediation. Missing evidence blocks a customer-value or ethics conclusion; benchmark findings do not automatically establish illegality. This remains a candidate rule with moderate confidence. [rule.transdigm.separate-moat-customer-outcomes]

Gate serial-acquirer capital. Keep acquisition cohorts, organic operations, required reinvestment, distributions and financing in separate deterministic bridges. Condition irreversible capital on cohort-return, cash, maturity, covenant and customer-outcome gates. This also remains a candidate rule: one case cannot calibrate thresholds or prove generality. [rule.transdigm.gate-serial-acquirer-capital]

Next research steps

  1. Independently acquire the exact SEC-hosted primary-document bytes under a configured SEC identity, compare them with the bound issuer-hosted annual-report PDFs and, if byte lineage verifies, rebind citations to the SEC carrier. That would support an earlier filing-time evidence cutoff; this packet does not backdate the later issuer-PDF renderings.
  2. Build an acquisition-cohort ledger covering purchase price, financing, purchase accounting, integration cost, organic operations, taxes, working capital, required engineering investment and realized cash return.
  3. Reconstruct instrument-level gross and carrying debt, interest, collateral, maturities, covenants, hedges and accessible cash under an approved downside scenario.
  4. Obtain product- and contract-level price-volume-cost-value, quality, alternatives, customer outcomes, OIG recommendation closure and any verified refund evidence.
  5. Only if an investment decision is authorized, add point-in-time security price, diluted capitalization, benchmarked return and an approved valuation model; until then, preserve abstention.

Open questions and caveats

  • Which acquisition cohorts generated returns above their fully loaded financing and reinvestment cost?
  • How much FY2025 organic growth came from price, volume, mix, defense outlays, aftermarket utilization and product changes?
  • Did the working group, policy actions, alternate sourcing or voluntary-refund requests reach verified closure after DODIG-2022-043?
  • What portion of consolidated margin is associated with government sole-source contracts, and what customer value or harm is independently measurable?
  • How would cash, maturities and covenant headroom behave under weaker aftermarket demand and tighter refinancing markets?

The model's OCF-less-selected-capex residual is not free cash flow, and the FY2015 capex input is net of disposals. Debt endpoints are non-comparable analyst-selected sums. OIG samples cannot be extrapolated to legality or portfolio-wide harm. No target price, TSR, acquisition IRR, covenant finding, solvency judgment or trade instruction is produced.

Part B source register

  • src.transdigm.outcome.fy2015-10k-issuer-pdf and src.transdigm.outcome.fy2015-10k-issuer-text — issuer-hosted FY2015 annual-report PDF and deterministic normalized-text derivative, SEC accession 0001260221-15-000013, classified tier 2 / primary issuer disclosure. The exact PDF SHA-256 is 7cdf1633c94b548976f5a7f3c7cb3aa5aae1757451d71d404746875d651c2b5c; its selected manifest is 9c9c8b20ad8137493166f76b7a9d6db76f422946a2911205153b84edf17d2baf. The exact carrier's public_at is conservatively the browser-download observation, 2026-08-16T19:45:51Z. PDF metadata identifies a 2019 rendering, so it is a retrospective carrier of 2015 filed content and is not marked contemporaneous. SEC acceptance establishes the underlying filing's availability, not availability of these exact PDF bytes. Issuer PDF, issuer filing page, official SEC index.
  • src.transdigm.outcome.fy2025-10k-issuer-pdf and src.transdigm.outcome.fy2025-10k-issuer-text — issuer-hosted FY2025 annual-report PDF and deterministic normalized-text derivative, SEC accession 0001260221-25-000081, classified tier 2 / primary issuer disclosure. The exact PDF SHA-256 is 3ecdb9f52e1dea89d047e64084da3463485c096e56cd8d81d9ed4fdff73125f5; its selected manifest is aa5adfb33e074e2c6cdcd8ad25ba53524a7b728d0ce5414d5cdff19780bdb8a9. PDF metadata records creation at 2025-11-12T21:17:46Z, after SEC acceptance, while exact-carrier public availability was verified only at the 2026-08-16T19:46:32Z browser observation. It is therefore not backdated or marked contemporaneous in this packet. Issuer PDF, issuer filing page, official SEC index.
  • src.dodig.outcome.transdigm-2019-060 — official DoD OIG PDF, DODIG-2019-060, issued February 25, 2019; date-only availability conservatively recorded at 2019-02-25T23:59:59Z. Classified tier 1 / primary government record. Official PDF, DoD OIG report page.
  • src.dodig.outcome.transdigm-2022-043 — official DoD OIG PDF, DODIG-2022-043, issued December 13, 2021; date-only availability conservatively recorded at 2021-12-13T23:59:59Z. Classified tier 1 / primary government record. Official PDF, DoD OIG report page.

Part A cutoff evidence reused for observable signals: evidence.transdigm.cutoff.business-model, evidence.transdigm.cutoff.acquisition-method, evidence.transdigm.cutoff.fy2014-sales-bridge, evidence.transdigm.cutoff.q1-sales-bridge, evidence.transdigm.cutoff.q1-acquisition-gross-profit, evidence.transdigm.cutoff.fy2014-balance-cashflow, evidence.transdigm.cutoff.q1-cash-flow, evidence.transdigm.cutoff.dividend-financing, evidence.transdigm.cutoff.telair-agreement, evidence.transdigm.cutoff.telair-conditions, evidence.transdigm.cutoff.non-gaap-boundary, and evidence.transdigm.cutoff.government-pricing-risk.

Observed after the cutoff

Outcome financials

8 tables

Later values do not backfill Part A. Definition changes, unknowns, and derived endpoints remain labeled.

GAAP and cash-flow endpointsAs Reported At Horizon · USDm
MeasureFY2014FY2015FY2025
Net sales2,372.90612,707.11518,8311
Gross profit1,267.87411,449.84515,3111
Income from operations927.8211,074.00214,1651
Net income306.911447.21212,0741
Interest expense-net347.6881418.78511,5721
Net cash provided by operating activities541.2221520.93812,0381
Capital expenditures (FY2015 net of disposals; positive cash-use magnitude)34.146154.87112221
Cash and cash equivalents at year-end819.5481714.03312,8081
USD · USDmReported values remain strings; no browser-side recalculation.
Deterministic margin and interest checksAnalyst Normalized · percent
MeasureFY2014FY2015FY2025
Gross margin53.4311derived53.5571derived60.141derived
Operating margin39.1011derived39.6731derived47.1631derived
Net margin12.9341derived16.521derived23.4851derived
Interest expense-net / net sales14.6521derived15.471derived17.8011derived
percentReported values remain strings; no browser-side recalculation.
Descriptive cash, debt and coverage scaleAnalyst Normalized · mixed_as_labeled
MeasureFY2014FY2015FY2025
Analyst-selected reported debt scale (USDm)7,473.1311derived8,427.3421derived30,0151derived
Reported debt scale less cash (USDm)6,653.5831derived7,713.3091derived27,2071derived
OCF less selected capex residual—not FCF (USDm; FY2015 net of disposals)507.0761derived466.0671derived1,8161derived
Reported debt scale / OCF (x; not covenant ratio)13.8081derived16.1771derived14.7281derived
Operating income / interest expense-net (x; not covenant ratio)2.6691derived2.5651derived2.6491derived
USD · mixed_as_labeledReported values remain strings; no browser-side recalculation.
Issuer-defined organic and acquisition sales changesAs Reported At Horizon · USDm
MeasureFY2015 vs FY2014FY2025 vs FY2024
Organic sales change7816151
Acquisition sales change256.212761
USD · USDmReported values remain strings; no browser-side recalculation.
Deterministic composition of reported sales changeAnalyst Normalized · percent
MeasureFY2015 vs FY2014FY2025 vs FY2024
Reported net-sales growth14.08412derived11.2221derived
Organic share of total sales change23.33912derived69.0241derived
Acquisition share of total sales change76.65912derived30.9761derived
percentReported values remain strings; no browser-side recalculation.
FY2014 to FY2025 descriptive endpoint bridgeAnalyst Normalized · mixed_as_labeled
MeasureFY2014 to FY2025
Net-sales change (USDm)6,458.09412derived
Net-sales CAGR (percent)12.6912derived
Operating-margin change (percentage points)8.06312derived
Analyst-selected reported debt-scale change (USDm; non-comparable perimeters)22,541.86912derived
USD · mixed_as_labeledReported values remain strings; no browser-side recalculation.
Issuer-stated cumulative acquisition count at filing dates—not fiscal-year operating perimeterAs Reported At Horizon · count
MeasureFY2015 filing dateFY2025 filing date (2025-11-12; includes Simmonds closed 2025-10-06)
Businesses and product lines acquired since 1993, as stated at filing date551951
countReported values remain strings; no browser-side recalculation.
FY2025 acquisition and distribution scaleAnalyst Normalized · mixed_as_labeled
MeasureFY2025
Acquisition cash use (USDm)4191
Dividends and dividend-equivalent payments (USDm)9,6291
September 2025 special dividend plus equivalents (USDm)5,2321derived
New debt for current special distribution (USDm)5,0001
FY2025 cash distributions / OCF (percent)472.4731derived
New debt / current special distribution (percent)95.5661derived
Acquisition cash / OCF-less-capex residual (percent; not return)23.0731derived
USD · mixed_as_labeledReported values remain strings; no browser-side recalculation.

Transferable—but not universal

Candidate decision rules

2 hypotheses

These rules are case-derived hypotheses. Each retains “unless” conditions, kill criteria, counterexamples, and promotion gaps.

Candidatemoderate confidence

rule.transdigm.separate-moat-customer-outcomes

Underwrite product necessity, switching, price-cost-value, customer alternatives, quality, legal compliance, audit findings and remediation as separate gates; abstain from a customer-value or ethics conclusion when any decision-critical gate lacks evidence.

The same source position can reflect genuine differentiated value, bargaining power, contested pricing or a mixture, so margin and recurrence cannot identify customer outcomes by themselves.

Use when

  • A company attributes durable economics to proprietary, sole-source, regulated or difficult-to-substitute products.
  • Customers include governments, safety-critical operators or other stakeholders whose alternatives and bargaining power may be constrained.

Do not transfer when

  • Independently verified product-level evidence shows immaterial customer concentration, abundant qualified alternatives and no material pricing or safety asymmetry.

Reverse or kill if

  • Stop favorable customer-value or ethics claims when material contract-level evidence is missing or contradicted.
  • Route any material unresolved legal, pricing, safety, quality or customer-harm conflict to authorized human review before external action or publication.
Limitations and promotion gaps
  • One case and two government samples cannot estimate a general rate of customer harm or rule effectiveness.
  • A benchmark-defined excess-profit finding is not automatically illegality, a universal profit ceiling or a portfolio-wide result.
Candidatemoderate confidence

rule.transdigm.gate-serial-acquirer-capital

Keep acquisition cohorts, organic operations, required reinvestment, distributions and financing in separate deterministic bridges; condition further irreversible capital on predeclared cohort-return, cash, maturity, covenant and customer-outcome gates.

Consolidated operating strength can coexist with purchased growth, refinancing dependence and cash distributions, while aggregate results conceal which cohorts earned fully loaded returns and which funding obligations remain fragile.

Use when

  • A serial acquirer combines material acquisition spending with debt financing, refinancing or shareholder distributions.
  • Consolidated growth and margins are available but stable acquisition-cohort cash returns and stressed funding headroom are not.

Do not transfer when

  • The transaction and distribution are demonstrably immaterial to liquidity, leverage, management capacity and customer continuity under approved thresholds.

Reverse or kill if

  • Stop or reprice the commitment if the cohort return cannot clear the approved downside hurdle on fully loaded cash flows.
  • Defer distributions and acquisitions when the stressed funding path is incomplete or breaches an approved buffer.
  • Re-underwrite after two consecutive material cohort, integration or funding-path misses.
Limitations and promotion gaps
  • The public TransDigm record does not supply cohort IRRs or a complete covenant model, so the rule is process-oriented and uncalibrated.
  • Debt and distributions are not inherently value-destructive; company-specific opportunity cost, taxes, financing terms and valuation matter.

Lineage

Complete case source ledger

13 records

This list combines decision-cutoff and outcome evidence. Each report citation resolves to a source ID below. Third-party documents remain with their original publishers.

T1

src.transdigm.cutoff.fy2014-10k

d789382d10k.htm

U.S. Securities and Exchange Commission · Nov 14, 2014

Regulatory FilingPrimaryContemporaneous

Used for: Audited financial reconstruction · Business model and acquisition-policy disclosure · Non-GAAP and government-pricing risk boundaries

T1

src.transdigm.cutoff.q1-2015-10q

d834606d10q.htm

U.S. Securities and Exchange Commission · Jan 30, 2015

Regulatory FilingPrimaryContemporaneous

Used for: Latest cutoff financial reconstruction · Organic and acquisition-sales bridge · Cash-flow, debt and interest scale

T1

src.transdigm.cutoff.telair-aar-8k

a15-5228_18k.htm

U.S. Securities and Exchange Commission · Feb 24, 2015

Regulatory FilingPrimaryContemporaneous

Used for: Signed Telair purchase agreement and announced price · Closing-condition boundary

T2

src.transdigm.outcome.fy2015-10k-issuer-pdf

TransDigm Group Incorporated FY2015 Form 10-K annual report

TransDigm Group Incorporated · Aug 16, 2026

Issuer DisclosurePrimary

Used for: Issuer-hosted rendering of the FY2015 filed report's content · Parent object for the deterministic text extraction used by material Part B citations

T2

src.transdigm.outcome.fy2025-10k-issuer-pdf

TransDigm Group Incorporated FY2025 Form 10-K annual report

TransDigm Group Incorporated · Aug 16, 2026

Issuer DisclosurePrimary

Used for: Issuer-hosted rendering of the FY2025 filed report's content · Parent object for the deterministic text extraction used by material Part B citations

T1

src.dodig.outcome.transdigm-2019-060

Review of Parts Purchased From TransDigm Group, Inc. (DODIG-2019-060)

U.S. Department of Defense Office of Inspector General · Feb 25, 2019

Court Or Government RecordPrimaryContemporaneous

Used for: Critical opposition on sole-source pricing and cost-data access · DoD OIG methodology and recommendation boundary · Parent object for deterministic text extraction